Mexican doctor hospitalized after receiving COVID-19 vaccine

By: |
January 3, 2021 10:40 AM

The doctor, whose name has not been released, was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing and a skin rash.

pizer vaccine, covid 19Pfizer and BioNTech could not immediately be reached for comment.More than 126,500 people have died from COVID-19 in Mexico. (Photo source: Reuters)

Mexican authorities said they are studying the case of a 32-year-old female doctor who was hospitalized after receiving the Pfizer-BioNTech COVID-19 vaccine.The doctor, whose name has not been released, was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing and a skin rash.

“The initial diagnosis is encephalomyelitis,” the Health Ministry said in a statement released on Friday night. Encephalomyelitis is an inflammation of the brain and spinal cord.The ministry added that the doctor has a history of allergic reactions and said that there is no evidence from clinical trials that anyone has developed an inflammation of the brain after the vaccine’s application.

Pfizer and BioNTech could not immediately be reached for comment.More than 126,500 people have died from COVID-19 in Mexico. The country began distributing the first round of COVID-19 vaccines to healthcare workers on Dec. 24.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 vaccine update: EU demands that vaccine makers honour their commitments
2COVID-19 in Delhi: 157 fresh cases, positivity rate slips to 0.24%
3WHO issues new clinical advice on treating COVID-19 patients